Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Diagnosis for Genetic Kidney Disease Through Early Genomic Assessment

NCT06794567 is registered in ClinicalTrials.gov with Dervla Connaughton as lead sponsor.

NCT NCT06794567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06794567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Diagnosis for Genetic Kidney Disease Through Early Genomic Assessment
Lead sponsor
Dervla Connaughton
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
December 31, 2028
Enrollment
2,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease(ckd), genetic kidney disease